Next, we investigated peptide-specific CD8+ T cell responses in PBMCs isolated from HLA-A*02:01 or HLA-B*40:01 positive COVID-19 patients (Fig. 3A, Table S5, Table S6). This evidence concerns the gene HLA-B and COVID-19.